Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Rubinstein

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
The Lancet. Haematology|August 18, 2020
COVID-19 and haematological malignancy: navigating a narrow straitSamuel M Rubinstein, Jeremy L Warner
JACC. Cardiooncology|November 3, 2021
How to Screen for Monoclonal Gammopathy in Patients With a Suspected AmyloidosisSamuel M Rubinstein, Keith Stockerl-Goldstein
Blood|August 28, 2020
Thrombosis in the modern era of multiple myelomaSamuel M Rubinstein, Sascha A Tuchman
European Journal of Cancer (Oxford, England : 1990)|June 12, 2023
Infection rates are high across the multiple myeloma continuum, not just with bispecific antibodiesSamuel M Rubinstein, Benjamin A Derman
JCO Clinical Cancer Informatics|January 18, 2019
CancerLinQ: Origins, Implementation, and Future DirectionsSamuel M Rubinstein, Jeremy L Warner
Current Neurology and Neuroscience Reports|June 23, 2025
Update on paraproteinemic neuropathyRebecca Traub, Samuel M Rubinstein, Christopher Dittus
JCO Clinical Cancer Informatics|January 29, 2020
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen ContentSamuel M Rubinstein, Peter C Yang, Andrew J Cowan, et al.
Acta Haematologica|February 8, 2022
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for TreatmentsJosé Carlos Martínez, R Alejandro Sica, Keith Stockerl-Goldstein, et al.
Annals of Hematology|October 17, 2024
Novel use of Siltuximab in a patient with VEXAS SyndromeBeatriz Cáceres-Nazario, Joshua Rivenbark, Manish K Saha, et al.
The Annals of Applied Statistics|August 6, 2024
BUILDING A DOSE TOXO-EQUIVALENCE MODEL FROM A BAYESIAN META-ANALYSIS OF PUBLISHED CLINICAL TRIALSElizabeth A Sigworth, Samuel M Rubinstein, Jeremy L Warner, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
The Lancet. Haematology|August 18, 2020
COVID-19 and haematological malignancy: navigating a narrow straitSamuel M Rubinstein, Jeremy L Warner
JACC. Cardiooncology|November 3, 2021
How to Screen for Monoclonal Gammopathy in Patients With a Suspected AmyloidosisSamuel M Rubinstein, Keith Stockerl-Goldstein
Blood|August 28, 2020
Thrombosis in the modern era of multiple myelomaSamuel M Rubinstein, Sascha A Tuchman
European Journal of Cancer (Oxford, England : 1990)|June 12, 2023
Infection rates are high across the multiple myeloma continuum, not just with bispecific antibodiesSamuel M Rubinstein, Benjamin A Derman
JCO Clinical Cancer Informatics|January 18, 2019
CancerLinQ: Origins, Implementation, and Future DirectionsSamuel M Rubinstein, Jeremy L Warner
Current Neurology and Neuroscience Reports|June 23, 2025
Update on paraproteinemic neuropathyRebecca Traub, Samuel M Rubinstein, Christopher Dittus
JCO Clinical Cancer Informatics|January 29, 2020
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen ContentSamuel M Rubinstein, Peter C Yang, Andrew J Cowan, et al.
Acta Haematologica|February 8, 2022
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for TreatmentsJosé Carlos Martínez, R Alejandro Sica, Keith Stockerl-Goldstein, et al.
Annals of Hematology|October 17, 2024
Novel use of Siltuximab in a patient with VEXAS SyndromeBeatriz Cáceres-Nazario, Joshua Rivenbark, Manish K Saha, et al.
The Annals of Applied Statistics|August 6, 2024
BUILDING A DOSE TOXO-EQUIVALENCE MODEL FROM A BAYESIAN META-ANALYSIS OF PUBLISHED CLINICAL TRIALSElizabeth A Sigworth, Samuel M Rubinstein, Jeremy L Warner, et al.
Pageof 6